| Keyword | CPC | PCC | Volume | Score | Length of keyword |
|---|---|---|---|---|---|
| sacituzumab govitecan mechanism | 0.31 | 0.3 | 3385 | 71 | 31 |
| sacituzumab | 1.3 | 0.1 | 2632 | 44 | 11 |
| govitecan | 0.36 | 0.3 | 68 | 97 | 9 |
| mechanism | 1.91 | 0.4 | 6402 | 64 | 9 |
| Keyword | CPC | PCC | Volume | Score |
|---|---|---|---|---|
| sacituzumab govitecan mechanism of action | 1.77 | 0.7 | 1590 | 17 |
| sacituzumab govitecan mechanism | 0.2 | 0.8 | 5234 | 87 |
| what is sacituzumab govitecan | 1.39 | 0.9 | 5977 | 14 |
| sacituzumab govitecan phase i | 1.44 | 0.3 | 9572 | 73 |
| sacituzumab govitecan patient information | 1.04 | 0.1 | 3205 | 46 |
| sacituzumab govitecan clinical trial | 1.82 | 0.4 | 1338 | 32 |
| sacituzumab govitecan j code | 1.01 | 0.1 | 4763 | 69 |
| sacituzumab govitecan prescribing information | 1.26 | 0.4 | 6802 | 1 |
| sacituzumab govitecan fiche patient | 1.34 | 0.3 | 3574 | 14 |
| sacituzumab govitecan drug class | 0.83 | 0.6 | 181 | 80 |
| sacituzumab govitecan-hziy | 0.14 | 0.2 | 1645 | 64 |
| sacituzumab govitecan effets secondaires | 1.74 | 0.6 | 1406 | 30 |
| sacituzumab govitecan brain metastases | 1.44 | 0.5 | 6934 | 13 |
| is sacituzumab govitecan immunotherapy | 0.58 | 0.3 | 9467 | 50 |
| ficha tecnica sacituzumab govitecan | 0.2 | 0.8 | 9587 | 36 |
| is sacituzumab govitecan chemotherapy | 2 | 1 | 3989 | 26 |
| sacituzumab govitecan immu-132 | 1.95 | 0.8 | 5062 | 71 |
| sacituzumab govitecan side effects | 0.33 | 0.8 | 3845 | 26 |
| sacituzumab govitecan breast cancer | 0.8 | 0.2 | 1272 | 84 |
